[RKLB]

Rocket Lab is targeting a mid-2027 Iridium close, projecting third-quarter 2026 revenue between $250 million and $265 million. Considering the possibility of profit-taking selling, I will take profits if the price reaches the high resistance level of $83.25 on the 20th, and I will cut losses if the low support level of $58.20 on the 20th is breached. The current price is near the 20-day high resistance level, and there is a possibility of profit-taking sales due to the recent surge over the past 7 days. Therefore, I will consider entering while keeping in mind both the potential for a breakout above the resistance level and risk management based on the support level. The technical indicators at the entry point are RSI(14) at 68.6, moving averages are misaligned, trading volume is 1.30 times the 20-day average, and the recent 7-day volatility is +41.3%. At the time of the forecast, a cautious approach was taken considering the possibility of profit-taking near the 20-day high resistance level ($83.25). However, the actual result was a FAILED rating with a significant drop of -12.9% towards the stop-loss price ($58.20). The recent surge of +41.3% over the past 7 days, the entry into the overbought territory with an RSI of 68.6, and the dilution risk from the CRITICAL rating of the 424B5 new share/securities offering announcement appear to have exerted strong downward pressure on the stock price. This trading experience has reaffirmed the necessity of conservative risk management when fatigue from short-term surges and high RSI levels are detected. In particular, it is important to keep in mind that when shareholder dilution factors, such as offering announcements, accompany the situation, it becomes difficult to maintain an upward trend even in the presence of positive news. Therefore, we will apply stricter stop-loss criteria and disclosure monitoring for future entries. Similar daily fluctuation patterns have been observed in the past, such as +2.5% on 2026-08-13 and +2.6% on 2026-08-11.

Rocket Lab has signed a $397 million contract with the U.S. Space Force for the production and launch of Flatellite. Due to the recent surge, there is upward pressure towards the resistance level of $86.50. Therefore, I will take profits upon reaching $86.50, and if the support level of $58.20 is breached, I will cut losses. We considered entering based on the key positive factor of a large contract with the U.S. Space Force and the recent upward trend over the past seven days. The current price is positioned between the resistance level of $86.50 and the support level of $58.20. The technical indicators at the entry point are RSI(14) at 48.2, moving averages are not aligned, trading volume is 1.01 times the 20-day average, and the recent 7-day volatility is +16.5%. The actual result recorded an OVERHIT judgment of 11.2%, surpassing the forecasted return of 5.0%. The strong catalyst of a $397 million Space Force contract, along with a +16.5% volatility over the past seven days, contributed to the upward momentum. However, amidst the neutral indicators of a misaligned moving average and an RSI of 48.2, we were able to observe how the upward pressure towards the resistance level ($86.50) is reflected in the actual stock price. We will actively incorporate the expectation that the continuation of a stronger trend than anticipated may be reflected in the next trading decisions, as fundamental positive factors such as large-scale contract wins align with the increasing trend of news within the theme (198 cases in the past 7 days). According to the pre-history of this stock, it showed a price reaction of +13.6% on 2026-07-27.